RxDoctor Payments Data

Enamul Haque, MD

Surgery of the Hand · Charlotte, NCNPI 1144351693

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Axogen at 35.8% of the total. Reporting peaked in 2024 at $2,913 and has fallen 81.3% since, to $544 in 2025.

$7,172in general payments, 2019–2025

Across 57 payments — averaging $125.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$3K
  • Musculoskeletal Transplant Foundation Inc.$2K
  • Medical Device Business Services, Inc.$1K
  • KCI USA, Inc.$800
  • Mentor Worldwide LLC$680
  • AbbVie$251
  • plus $101 from 2 others

What the payments were for

  • Consulting fees$80011%
  • Travel & lodging$3,66451%
  • Food & beverage$2,67937%
  • Entertainment$300%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few surgery of the hand providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$38,655
Medicare patients
52
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin25$144
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$135
Ondansetron Hcl23$111
Oxycodone Hcl22$84

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →